Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tetraspanin-32 (TSPAN32) is a member of the tetraspanin superfamily, a group of four-pass transmembrane proteins that play roles in cell-cell interactions, membrane organization, and signal transduction, particularly in hematopoietic tissues[1][2]. TSPAN32 is considered a tumor suppressor and is located in the imprinted gene domain of chromosome 11p15.5, a region frequently implicated in several cancers and Beckwith-Wiedemann syndrome[1][4]. Its expression is primarily confined to hematopoietic cells, and it is involved in regulating processes such as proliferation, apoptosis, immune response, and maintenance of hematopoietic function[1][2][4]. Unlike many tetraspanins, Tetraspanin-32 exhibits tumor-suppressive actions: its overexpression can inhibit leukemia progression and the proliferation of leukemia stem cells[2]. Alterations in the TSPAN32 gene or its regulatory region are associated with increased susceptibility to cancers and hematological disorders[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tetraspanin-32 (TSPAN32).